Tags

Type your tag names separated by a space and hit enter

Heterologous and sex differential effects of administering vitamin A supplementation with vaccines.
Trans R Soc Trop Med Hyg 2015; 109(1):36-45TR

Abstract

WHO recommends high-dose vitamin A supplementation (VAS) to children from 6 months to 5 years of age in low-income countries, in order to prevent and treat vitamin A deficiency-associated morbidity and mortality. The current policy does not discriminate this recommendation either by sex or vaccination status of the child. There is accumulating evidence that the effects of VAS on morbidity, mortality and immunological parameters depend on concomitant vaccination status. Moreover, these interactions may manifest differently in males and females. Certain vaccines administered through the Expanded Program on Immunization have been shown to alter all-cause mortality from infections other than the vaccine-targeted disease. This review summarizes the evidence from observational studies and randomized-controlled trials of the effects of VAS on these so-called heterologous or non-specific effects of vaccines, with a focus on sex differences. In general, VAS seems to enhance the heterologous effects of vaccines, particularly for diphtheria-tetanus-pertussis and live measles vaccines, where some studies, although not unanimously, show a stronger interaction between VAS and vaccination in females. We suggest that vaccination status and sex should be considered when evaluating the effects of VAS in early life.

Authors+Show Affiliations

Research Center for Vitamins & Vaccines (CVIVA), Bandim Health Project, Statens Serum Institut, DK-2300 Copenhagen S, Denmark Projécto de Saúde Bandim, Indepth Network, Apartado 861,Codex 1004, Bissau, Guinea-Bissau.MRC Laboratories, Fajara, The Gambia.Vaccine and Infectious Diseases Laboratory, Department of Immunology, Monash University, 89 Commercial Road, Prahran, Victoria 3004, Australia.Vaccine and Infectious Diseases Laboratory, Department of Immunology, Monash University, 89 Commercial Road, Prahran, Victoria 3004, Australia katie.flanagan@dhhs.tas.gov.au.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

25477326

Citation

Jensen, Kristoffer J., et al. "Heterologous and Sex Differential Effects of Administering Vitamin a Supplementation With Vaccines." Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 109, no. 1, 2015, pp. 36-45.
Jensen KJ, Ndure J, Plebanski M, et al. Heterologous and sex differential effects of administering vitamin A supplementation with vaccines. Trans R Soc Trop Med Hyg. 2015;109(1):36-45.
Jensen, K. J., Ndure, J., Plebanski, M., & Flanagan, K. L. (2015). Heterologous and sex differential effects of administering vitamin A supplementation with vaccines. Transactions of the Royal Society of Tropical Medicine and Hygiene, 109(1), pp. 36-45. doi:10.1093/trstmh/tru184.
Jensen KJ, et al. Heterologous and Sex Differential Effects of Administering Vitamin a Supplementation With Vaccines. Trans R Soc Trop Med Hyg. 2015;109(1):36-45. PubMed PMID: 25477326.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Heterologous and sex differential effects of administering vitamin A supplementation with vaccines. AU - Jensen,Kristoffer J, AU - Ndure,Jorjoh, AU - Plebanski,Magdalena, AU - Flanagan,Katie L, Y1 - 2014/12/03/ PY - 2014/12/6/entrez PY - 2014/12/6/pubmed PY - 2015/9/25/medline KW - All-cause mortality KW - BCG vaccine KW - DTP vaccine KW - Measles vaccine KW - Sex KW - Vitamin A SP - 36 EP - 45 JF - Transactions of the Royal Society of Tropical Medicine and Hygiene JO - Trans. R. Soc. Trop. Med. Hyg. VL - 109 IS - 1 N2 - WHO recommends high-dose vitamin A supplementation (VAS) to children from 6 months to 5 years of age in low-income countries, in order to prevent and treat vitamin A deficiency-associated morbidity and mortality. The current policy does not discriminate this recommendation either by sex or vaccination status of the child. There is accumulating evidence that the effects of VAS on morbidity, mortality and immunological parameters depend on concomitant vaccination status. Moreover, these interactions may manifest differently in males and females. Certain vaccines administered through the Expanded Program on Immunization have been shown to alter all-cause mortality from infections other than the vaccine-targeted disease. This review summarizes the evidence from observational studies and randomized-controlled trials of the effects of VAS on these so-called heterologous or non-specific effects of vaccines, with a focus on sex differences. In general, VAS seems to enhance the heterologous effects of vaccines, particularly for diphtheria-tetanus-pertussis and live measles vaccines, where some studies, although not unanimously, show a stronger interaction between VAS and vaccination in females. We suggest that vaccination status and sex should be considered when evaluating the effects of VAS in early life. SN - 1878-3503 UR - https://www.unboundmedicine.com/medline/citation/25477326/Heterologous_and_sex_differential_effects_of_administering_vitamin_A_supplementation_with_vaccines_ L2 - https://academic.oup.com/trstmh/article-lookup/doi/10.1093/trstmh/tru184 DB - PRIME DP - Unbound Medicine ER -